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Summary and Key Points 
1. Cancer patients are at risk for oncologic and metabolic crises.
These effects may be caused by the cancer, the treatment
provided to cure or palliate the cancer, and/or other medical
conditions. They may occur at initial presentation, as a first
sign of disease or during the disease course.
2. Oncologists divide these crises into emergencies and
urgencies, depending on the severity of the consequences of
delay in treatment.
3. Table 1. Emergencies versus urgencies
Emergencies Urgencies 
Spinal Cord Compression & 
Cauda Equina Syndrome 
Superior Vena Cava 
Syndrome 
Cardiac Tamponade Respiratory Compromise 
Uncal Herniation Brain Metastases 
Metabolic Emergencies Carcinomatous Meningitis 
Hypercalcemia Deep Venous Thrombosis 
Acute Tumor Lysis Syndrome Pain 
Hyponatremia Tumor Bleeding 
Febrile neutropenia Pulmonary Embolism 
Seizures Anemia & dehydration 
4. Remember that any one of these conditions may be the first
clinical evidence of an undiagnosed cancer.
Introduction 
The American Cancer Society estimates in 2014 more than 1.6 
million Americans will be diagnosed with cancer and almost 600, 000 
will die1. This excludes Americans with basal and squamous cell skin 
cancers. Almost 14 million people were alive after a diagnosis of 
cancer on January 1, 20121. Therefore, every health care provider 
should be aware of the signs and symptoms of oncologic urgencies 
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and emergencies and initial management. 
Any of these conditions can occur at any point in the course of 
illness. It is particularly important to remember that one of these 
conditions may be the first clinical evidence of an undiagnosed 
cancer. 
Oncologic Emergencies 
Spinal Cord Compression (SCC) and Cauda Equina Syndrome 
Presentation 
SCC typically is a syndrome with a long prodrome, which is back 
pain. If the symptom is not attended to, it will predictably progress to 
paralysis. The pain can be localized in the central back, or may 
radiate out laterally on one or both sides (unilaterally or bilaterally). A 
change in the nature or severity of pre-existing back pain in a patient 
known to have a malignancy should be considered a warning sign. 
Often, patients will report that they have had progressive pain over 
the preceding two weeks by the time they are paralyzed. However, 
patients with SCC may present with chronic back pain. Because 
back pain is such a common presenting complaint, it is appropriate to 
consider obtaining radiographic studies on patients with back pain 
accompanied by a neurologic deficit. When SCC is suspected, plain 
radiographs and bone scans are not definitive; the patient should go 
directly to spine MRI (Figure 1). 
Figure 1a. A 56 yo female presents with progressive lower extremity 
weakness, numbness, and spasticity and worsening bowel and bladder 
function. MRI of the thoracic spine demonstrates a mass resulting in severe 
compression of the spinal cord. Figure 1b. Resection of this lesion yielded a 
schwannoma. Two years later, the patient presents with recurrent 
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symptoms. A CT myelogram was performed. Contrast injected into the 
thecal sac outlines a focal mass causing severe compression of the spinal 
cord, representing recurrence of the schwannoma at the same site. 
University of Massachusetts Medical School, Department of Radiology. 
Patients may experience a Brown-Seguard like pattern of numbness. 
The pain may mimic the pain of shingles, as a single dermatome will 
often be affected. The pain level provides a clue to the vertebral level 
involved. It must be remembered that the nerve roots actually arise 
several levels superior to the egress foramen, so the anatomic level 
may be above the symptomatic dermatome. Spinal tenderness and 
up-going toes indicating upper motor neuron compression are useful 
additional clues to the presence of spinal metastasis with cord 
involvement. 
If the condition is diagnosed and treated before paralysis sets in, 
patients may continue to walk. Once motor paralysis and particularly 
once autonomic dysfunction sets in, the process is almost always 
irreversible. Autonomic dysfunction initially causes constipation and 
urinary retention, but will progress to incontinence of urine and stool. 
This catastrophic outcome is a reason that spinal cord compression 
is considered a true medical emergency. 
Cauda Equina Syndrome 
Compression of the cauda equina, which is below L1 in most adults, 
causes identical signs and symptoms, has the same etiology and is 
managed identically to SCC. It is referred to as cauda equina 
syndrome. 
Mechanism & Etiology 
Etiology 
Compression of the spinal cord or  cauda occurs when: 
• Tumor within a vertebra grows into the spinal canal or a
pathologic fracture drives bone fragments into the cord.
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• Paraspinal tumor grows through the vertebral openings into
the epidural foramen.
• Metastatic tumor grows through the epidural space and
impinges on the dura.
Tumors can cause spinal cord compression in several ways. The 
most common is a bony metastasis growing out of bone as soft 
tissue extension into the canal or pushing bone fragments into the 
neural structures (Figures 2 & 3.). While the neural foramen may be 
compressed similarly and may cause symptoms, this compression 
alone will cause pain, but not paralysis. A paravertebral mass may, 
however, grow through a foramen into the canal without involving the 
bone. Epidural or parenchymal metastases may cause compression. 
Pain from an epidural lesion is usually in a dermatome distribution. 
Figure 2a. A 64 yo male presents with severe acute onset neck pain with 
both upper and lower extremity weakness and numbness. Coronal CT 
reformat demonstrates lytic metastasis to the left occipial condyle and right 
lateral mass of C1. Weaking of the bone has resulted in a pathologic 
fracture of the right lateral mass of C1 with loss of vertebral height. On 
further workup, a lung mass was identified and biopsy returned non-small 
cell lung cancer. Figure 2b is provided as comparison of normal anatomy. 
University of Massachusetts Medical School, Department of Radiology. 
Figure 3a. A 54 yo female presents with progressively worsening neck pain 
over several weeks. Sagittal T2 weighted MRI sequence demonstrates an 
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unstable pathologic fracture of the C4 vertebral body. Figure 3b from an 
intraoperative radiograph shows that this lesion has essentially replaced the 
vertebral body. Figure 3c is a postoperative radiograph after placement of 
an interbody spacer in the cavity created by removing the tumor. An anterior 
plate with anterior fixation screws span C3-C5 stabilizes these levels. 
Tissue sampling of this lesion was consistent with renal cell carcinoma. 
University of Massachusetts Medical School, Department of Radiology. 
Treatment 
Management of spinal cord compression requires decreasing 
pressure on cord. The first step is dexamethasone to decrease 
swelling. The mainstay of treatment for spinal cord compression has 
been radiotherapy, with chemotherapy reserved for chemo-sensitive 
tumors, such as lymphomas. Surgery has traditionally been used 
when diagnosis is required, or symptoms progress during 
radiotherapy or after full dose radiation to the volume, or if bone 
fragments are seen to be involving cord. With recent improvements 
in surgical techniques, more patients are benefitting from early 
surgical decompression, usually followed by postoperative 
radiotherapy. 
Return to beginning of chapter 
Neoplastic Cardiac Tamponade 
Suspect neoplastic cardiac tamponade in any oncology patient 
presenting with dyspnea and hypotension. This is not common, 
however, tamponade must be thought of emergently, so that 
lifesaving pericardiocentesis is not delayed. Neoplastic cardiac 
tamponade may result from post-radiation pericarditis (acute or up to 
a year after treatment), fibrosis, or pericardial metastases. It may 
also result from the physical encroachment of benign tumors on the 
heart and resultant fluid buildup. Clinical suspicion can be supported 
by ultrasound, chest x-ray showing the classic “water bottle” heart, 
EKG showing low voltage QRS complexes, and/or the finding of 
pulsus alternans. 
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Management 
Consult cardiothoracic surgery if available, or general surgery. 
Treatment involves pericardiocentesis and may require creation of a 
pericardial window. 
Return to beginning of chapter 
Uncal Herniation 
The brain is confined in the rigid skull. As a result, additional tissue or 
swelling in the brain can increase intracranial pressure. Either 
primary brain cancers or metastases in the brain can cause brain 
tissue to press into the base of the skull and protrude through the 
foramen magnum. Temporal lobe pressure can transmit laterally and 
force the uncus, which contains the respiratory drive center, into the 
foramen magnum. The patient will have impaired brainstem function, 
rapid loss of consciousness and respiratory drive. Pressure on other 
areas of the brain can present with a myriad of other symptoms such 
as headache, vomiting, hiccups, and mental status changes. 
Management 
Immediate treatment is directed at airway protection for ventilatory 
support, and mannitol, up to 1g/kg IV, to reduce intracranial pressure 
Return to beginning of chapter 
Metabolic Emergencies 
Hypercalcemia (>14 mg/dl) 
Etiology 
• Direct Tumor Destruction of Bones
• Parathyroid Hormone-Related Protein
• Increased Vitamin D synthesis in some tumors, especially
Hodgkin’s lymphoma
Presentation 
Table 2 lists the malignant diagnoses that can result in 
hypercalcemia. It is important to appreciate, that most non-malignant 
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causes of hypercalcemia produce a relatively slow rise in plasma 
calcium levels compared to hypercalcemia of malignancy. Signs and 
symptoms of hypercalcemia present much more acutely in the 
setting of cancer. These clinical findings include delirium, stupor, 
coma, muscle weakness, anorexia, constipation, cardiac 
arrhythmias, and renal failure. 
Table 2. Malignant Conditions That May Result in Hypercalcemia 
Renal Cell Carcinoma 
Lymphoma 
Breast Cancer 
Myeloma 
Non-small Lung Cell Carcinoma 
Prostate cancer, despite its propensity to metastasize to the bones, 
is rarely associated with hypercalcemia because bone metastases 
from prostate cancer are usually blastic, not lytic. 
Mechanism 
Two general mechanisms have been identified by which cancers can 
cause hypercalcemia. A number of solid tumors (e.g., non-small cell 
lung cancer, renal cell carcinoma) can secrete hormones that 
increase bone resorption in the absence of overt bone metastases. 
These hormones include parathyroid-related peptide. This is a para-
neoplastic phenomenon. In addition to using humoral factors, some 
cancers (e.g., myeloma, breast cancer) can also directly invade bone 
and cause osteolysis. 
Ninety-nine percent of total body calcium is stored in bones, which 
are constantly being remodeled. Osteoclasts resorb established 
bone and osteoblasts lay down new bone. Hypercalcemia of 
malignancy is due to an imbalance in the remodeling process. There 
is almost always an increase in bone resorption resulting in release 
of calcium from bone into extracellular fluids. Osteoblasts may also 
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be inhibited from utilizing calcium to mineralize bone. Although the 
kidneys are usually able to respond to elevations in plasma calcium, 
they are overwhelmed in the setting of massive calcium mobilization. 
Hypercalcemia itself can impair renal function by causing 
nephrocalcinosis or volume depletion. 
Calcium homeostasis is maintained by intricate hormonal regulation 
involving calcitonin, parathyroid hormone, and vitamin D (1,25-
dihydroxyvitamin D3). A normal level of ionized calcium in 
extracellular fluids is critical for proper nerve and muscle function. 
Hypercalcemia due to malignancy can result in very high plasma 
levels of calcium and can be life-threatening. 
Management 
Treatment of hypercalcemia of malignancy is directed at prompt 
reduction of calcium levels. This is particularly important for patients 
who are symptomatic or who have calcium levels above 13.5 mg/dl. 
Elimination of factors that can contribute to hypercalcemia (thiazide 
diuretics, calcium and vitamin D supplements) is important. Most 
patients will be severely volume depleted and aggressive hydration 
with normal saline is a cornerstone of treatment. 
Bisphosphonates have now become the pharmacologic agents of 
choice in the treatment of hypercalcemia of malignancy. Pamidronate 
and zoledronic acid are both given intravenously and will result in 
normocalcemia in up to 90% of patients. Zoledronic acid does 
appear to be slightly superior to pamidronate. Other drugs that may 
be used in patients who do not respond to bisphosphonates include 
gallium nitrate, calcitonin, and glucocorticoids. Recently the anti-
RANK ligand antibody denosumab has been reported to correct 
hypercalcemia of malignancy in patients previously treated with 
bisphosphonates. However, the use of denosumab in this setting 
Oncologic Emergencies and Urgencies 
Richard S. Pieters, MD 
Joyce Rosenfeld, MD 
Andrew Chen, MD 
James Liebmann, MD 
9 
Oncologic Emergencies and Urgencies 
11 February 2015 
remains experimental. 
Return to beginning of chapter 
Tumor Lysis Syndrome (TLS) 
Etiology 
TLS is caused by the rapid breakdown of tumor with: 
• Increased K+ and PO4 into circulation
• Increased Urate from DNA breakdown
• Urate and CaPO4 precipitation in renal tubules
Presentation 
Cell death results in the loss of cell membrane integrity and the 
release of intracellular contents into the extracellular space. These 
contents undergo metabolism and eventual excretion primarily via 
the kidneys. If a large number of cells suddenly die, the ability of the 
kidneys to clear the products of cell necrosis may be compromised. 
TLS refers to the host of metabolic abnormalities that can result from 
cell death. Though it can be observed in patients with rapidly growing 
tumors, TLS is most commonly seen after chemotherapy treatment 
of bulky drug-sensitive tumors. 
It can also be seen after initiation of radiotherapy for bulky, 
radiosensitive tumors. The malignancies with the highest risk of TLS 
after treatment include the acute leukemias and high-grade non-
Hodgkin lymphomas. 
Patients at highest risk of TLS are those within the first five days of 
the start of chemotherapy or radiotherapy for rapidly growing tumors. 
Risk increases with volume of tumor and with the presence of 
hyperurecemia or preexisting renal insufficiency. There is a 
correlation between elevated lactate dehydrogenase (LDH) and 
development of TLS. 
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Mechanism 
Potassium, phosphate, and purines are all released by cells after 
death. Purines are metabolized to uric acid, which is poorly soluble in 
acidic urine and so can precipitate in urine and cause an obstructive 
uropathy. The subsequent renal damage can make the hyperkalemia 
and hyperphosphatemia resulting from cell lysis worse by impairing 
the ability of the kidney to clear these substances. Hyperkalemia can 
cause cardiac arrhythmias and conduction disturbances. Muscle 
weakness, cramping and paresthesia can also arise from 
hyperkalemia. Hyperphosphatemia causes a secondary 
hypocalcemia as a result of precipitation of calcium phosphate. 
Hypocalcemia can cause muscle spasms, mental status changes, 
hypotension, and may worsen the cardiac conduction abnormalities 
caused by hyperkalemia. Cardiac arrhythmias and renal failure could 
be fatal. 
Management 
TLS is best prevented rather than treated. Patients at risk should 
receive aggressive intravenous hydration prior to starting anti-cancer 
therapy. They should also receive allopurinol, an inhibitor of xanthine 
oxidase, to block the conversion of xanthine and hypoxanthine to uric 
acid. Fluids used for hydration could contain sodium bicarbonate in 
order to alkalinize the urine to increase the solubility of uric acid, 
though alkaline urine may increase the risk of precipitation of 
calcium-phosphate salts. Oral phosphate binders can be given to 
lower the risk of hyperphosphatemia. 
If TLS does occur, aggressive hydration should be continued to 
maintain good urinary output. Allopurinol should also be continued 
and recombinant urate oxidase (rasburicase) can be given to 
patients with hyperuricemia. A single dose of rasburicase is generally 
sufficient. Hyperkalemia should be treated with oral cation exchange 
Oncologic Emergencies and Urgencies 
Richard S. Pieters, MD 
Joyce Rosenfeld, MD 
Andrew Chen, MD 
James Liebmann, MD 
11 
Oncologic Emergencies and Urgencies 
11 February 2015 
resins, loop diuretics, and sodium bicarbonate. Patients who develop 
acute renal failure should receive hemodialysis. 
It is important to appreciate that the cancers most likely to develop 
TLS are potentially curable, so aggressive supportive care in the 
acute treatment setting can prove to be life-saving. 
Return to beginning of chapter 
Hyponatremia 
Etiology 
Table 3. Conditions that May Cause Hyponatremia 
(SIADH) Syndrome of inappropriate antidiuretic hormone secretion: 
Common Malignancies: Small cell lung cancer 
CNS tumors: Glioblastoma, Metastatic Disease 
Chemotherapy drugs: Cyclophosphamide, Vinca Alkaloids 
Adrenal gland insufficiency: Addison's disease 
Underactive thyroid: Hypothyroidism 
Dehydration 
Kidney problems 
Presentation 
Sodium is the principle cation in extracellular fluid. The concentration 
of sodium will affect nerve conduction and muscle function. As serum 
sodium levels fall below 125 mEq/L, patients can develop 
generalized weakness, anorexia, altered mental status, seizures, and 
coma. Hyponatremia can occur for a variety of reasons in patients 
with cancer. Table 3 lists some of the causes of hyponatremia. In 
patients with cancer, SIADH should be considered. 
Mechanism 
Antidiuretic hormone (ADH, arginine vasopressin, AVP) is 
synthesized in neurons in the hypothalamus and migrates down the 
axons of those neurons to be released into the bloodstream in the 
posterior pituitary. ADH binds to renal collecting duct cells and 
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makes the kidney permeable to water. SIADH can occur when there 
is ectopic production of ADH or when there is dysregulation of 
production of ADH from the hypothalamus. In cancer patients, 
SIADH can be a paraneoplastic syndrome resulting from the ectopic 
production of ADH by tumor cells. This occurs most commonly in 
patients with lung cancer, especially small cell lung cancer. SIADH 
can also be a complication of treatment. A number of chemotherapy 
drugs, including cyclophosphamide, vinca alkaloids, and some drugs 
used for supportive care, such as opiates and phenothiazines, can 
cause SIADH. 
Management 
Patients with severe hyponatremia (serum sodium less than 115 
mEq/L) should be treated with normal or hypertonic saline hydration. 
Care should be taken not to correct the hyponatremia too rapidly– 
there is an increased risk of long-term neurologic damage from 
central pontine myelinolysis with overly aggressive correction of 
hyponatremia. Patients with less severe hyponatremia can frequently 
control their sodium levels with moderate restriction of water intake. 
The oral antibiotic demeclocycline, which blocks the effect of ADH on 
the renal tubule, can also be used to control sodium levels in patients 
with SIADH. Recently, two ADH receptor antagonists, conivaptan 
and tolvaptan, have also been approved for the treatment of SIADH. 
Return to beginning of chapter 
Febrile Neutropenia 
Infection is a leading proximal cause of cancer deaths. Neutropenia 
is a common side effect of chemotherapy, Remember that most 
fevers have an infectious etiology, but tumor necrosis, homeostatic 
imbalance from CNS dysfunction, and various medical interventions 
may also result in elevated temperature. 
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Management 
Evaluate the patient carefully for a source of infection, especially all 
lines and ports, then obtain blood cultures, and immediately start 
broad-spectrum antibiotics. 
Return to beginning of chapter 
Oncologic Urgencies 
Pain 
Presentation 
Pain from cancer tends to have a typical presentation despite 
variation in the pathophysiology due to different etiologies. Although 
there are exceptions, the pain tends to present gradually. Cancer 
pain is usually continuous, progressively more severe, and unlike 
any previous pain the patient has experienced. Pain from increased 
intracranial pressure is an exception, as it tends to be worse in the 
morning. Pain is subjective and severity must be patient reported. 
. 
Mechanism 
It is important to realize that, although the public perception of cancer 
is that it is always very painful, only about 50% of cancer patients will 
experience physical pain during the course of their illness. In 
addition, even for patients who do experience pain, most of the 
course of their illness will be pain free. Essentially all cancer patients 
experience psychological or emotional pain, and many experience 
physical or emotional pain from treatment side effects. Psychic and 
spiritual pain often exacerbates physical pain. 
Management 
Treatment of the underlying malignant cause may relieve the pain. 
For a responsive tumor, chemotherapy may cause enough response 
to palliate pain in certain circumstances. Surgery may be required to 
palliate pain in situations where the pain is due to an impending or 
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actual fracture, or to place a stent to relieve obstruction. Most 
frequently, however, radiation therapy is the treatment with the 
greatest likelihood of relieving pain, especially bone pain and from 
Glisson’s capsule distention around an enlarged liver. While the 
response rates for palliation by radiotherapy vary a bit by tumor 
histology, roughly 2/3-3/4 of patients will have significant relief. In at 
least 50% of responders, the relief will be durable. Injections, nerve 
blocks, and neuraxial infusions may be useful in selected cases. 
For most patients and for the interval until the above treatments can 
become effective, the cornerstone of medical pain management is 
pharmacological, utilizing the WHO pain pyramid. 
It is well documented that pain management is inadequate far too 
often, even among patients who are actively undergoing treatment 
on a regular basis. This may be due to inadequate pain assessment, 
failure to prescribe analgesic, or patient or provider fear of addiction 
or legal problems.3 However, pain is considered the fifth vital sign, to 
be assessed and managed at every visit. 
On occasion, pain becomes so severe that it is referred to as a pain 
crisis; this is a true medical emergency, and should lead to a 
palliative medicine consult, if available, and continuous physician 
supervision of medical pain intervention until relief is achieved. 
Return to beginning of chapter 
Tumor Bleeding 
Presentation 
Tumor bleeding can present dramatically as massive hemoptysis, 
vaginal, rectal or urinary bleeding or it can be quite subtle, presenting 
as unexplained anemia. Anemia that arises gradually as the result of 
a tumor that is slowly oozing blood will frequently be due to iron 
deficiency as the result of chronic loss of iron. In this case, red cells 
Oncologic Emergencies and Urgencies 
Richard S. Pieters, MD  
Joyce Rosenfeld, MD 
Andrew Chen, MD 
James Liebmann, MD 
 
 
15 
Oncologic Emergencies and Urgencies 
11 February 2015 
will typically be microcytic. Unexplained microcytic anemia due to 
iron deficiency should be considered a gastrointestinal malignancy 
until proven otherwise. 
  
Occasionally tumors within the central nervous system may bleed 
into themselves, presenting as a cerebrovascular accident. 
 
  
Mechanism  
The most common physiology is bleeding from friable, abnormal 
tumor vasculature. But on rare occasions, a tumor may invade 
through a blood vessel wall. If the affected vessel is a major artery, 
the bleeding may be massive and rapidly fatal. On the other hand, if 
the affected vessel is a minor vein, the bleeding may look just like 
bleeding from abnormal tumor vessels. 
 
  
Treatment  
The treatment of tumor bleeding depends on the location of the 
tumor and the anatomy of the normal structures surrounding it. 
Volume replacement support and consideration of transfusion is the 
first step. It may be possible for an interventional radiologist to block 
the feeding vessels, provided that would not damage vital 
surrounding tissue. Similarly surgical ligation of these feeding 
vessels would stop the bleeding. If it is possible to resect the tumor, 
that would be the most rapid intervention. For chemo-sensitive 
tumors, chemotherapy may work. 
 
  
Most commonly radiation therapy is used. For brain lesions, it is 
usually the only option. For tumors elsewhere in the body, it is 
usually the most cost effective and least invasive treatment available. 
With conventional fractionation bleeding usually takes about two 
weeks to stop (and it almost always does stop). However, a single 
large radiotherapy dose will usually work much more rapidly. 
Unfortunately such a large fraction may make it difficult to deliver 
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definitive radiotherapy to a tumor, so it is rarely done in the United 
States, as most American radiation oncologists are accustomed to 
conventional fractionation. British and Canadian physicians are more 
likely to use large fraction sizes in this situation. 
While exsanguination can be a terminal event, if a patient is 
minimally symptomatic and a blood bank is available, tumor bleeding 
usually is treated routinely rather than emergently. 
Return to beginning of chapter 
Pulmonary Embolism 
Etiology 
Pulmonary embolism occurs when a blood clot in a large vein, 
usually in the lower legs or pelvis, breaks free and moves through 
the right heart into the pulmonary arteries. Cancer patients are at 
particular risk of developing thromboses. (See Paraneoplastic 
Syndromes chapter). Though not actually described by the eminent 
German pathologist Rudolf Virchow, conditions now known as 
Virchow’s Triad increase the risk of developing a clot. These are 
damage to blood vessel walls, stasis of venous blood flow, and 
hypercoagulability of blood. Cancers can lead to all three of these 
situations. Tumors can damage vessel walls. Cancer patients, 
especially late in the course of the disease, like long distance airline 
passengers, are relatively immobile, with extended periods sitting or 
lying in bed, which can lead to venous stasis. And some 
malignancies, for uncertain reasons, can cause hypercoagulability 
and migratory thrombophlebitis. 
Presentation 
Patients with pulmonary embolism can present with the abrupt onset 
of shortness of breath or chest pain These symptoms can be severe. 
Large pulmonary emboli which obstruct a large fraction of the cardiac 
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output from the right side of the heart and cause hypotension and 
even sudden death. Most symptomatic pulmonary emboli arise from 
veins in the pelvis or thighs. Complaints of pain, swelling, redness, or 
warmth along a lower extremity should raise the possibility of a 
venous thrombus in the affected limb. 
Diagnosis 
If there is concern that a patient may have a deep vein thrombosis in 
the pelvis or a lower extremity, Doppler ultrasound (Figure 4.) to 
assess flow in the large veins of the extremity and pelvis should be 
performed. Patients with severe chest pain and shortness of breath 
could be evaluated with a CT of the chest with IV contrast on a 
pulmonary embolism protocol (Figure 5). 
Figure 4. Ultrasound of the right lower extremity was obtained due to 
asymmetric leg swelling. Figures 6a and 6b demonstrate abnormal 
heterogeneously increased echogenicity in the femoral vein and deep 
femoral vein when compared with the adjacent arteries. Figure 6c a color 
Doppler, shows vascular flow in the arterial system (mixture of red and blue 
colors) and no flow in the venous system. This is deep venous thrombosis. 
University of Massachusetts Medical School, Department of Radiology. 
Figure 5. A 45 yo male with a known history of renal cell carcinoma 
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presents with acutely worsening shortness of breath. CT angiography was 
performed and a large pulmonary embolus was found. The unique location 
of the pulmonary embolus draped across the bifurcation of the main 
pulmonary artery is known as a saddle embolus. University of 
Massachusetts Medical School, Department of Radiology. 
Management 
The foundation of management of pulmonary embolism or deep vein 
thrombosis is anticoagulation. Patients with active malignancies may 
benefit from long-term anticoagulation, as their risk of recurrent clot 
is very high if anticoagulation is stopped. 
Return to beginning of chapter 
Respiratory Compromise 
Etiology 
Malignancy can cause respiratory distress through three primary 
mechanisms (Table 4). While most of the time, respiratory 
compromise is a medical emergency, for oncologists, after initial 
stabilization, it is only urgent. The reason for this statement is that, if 
the patient is in severe distress, intubation and ventilation is required. 
Once that is accomplished and the airway is secure, there is time for 
whatever treatment required to be delivered. On the other hand, if 
this cannot be accomplished or is ineffective, the patient is usually 
beyond help. One exception would be an exquisitely sensitive tumor, 
which will respond rapidly to radiotherapy or chemotherapy. A 
second exception would be a situation where bronchoscopic suction 
or a laser resection will relieve the obstruction. 
Table 4. Etiologic Mechanisms of Malignant Respiratory Distress 
Primary 
Mechanism 
Airway 
Obstruction 
Damage to Lung 
Parenchyma 
Lung Collapse 
  Mucous plug   Direct tumor 
  destruction 
  Pleural 
  effusion 
  Intrinsic tumor   Post-obstructive 
  pneumonia  
  Pneumothorax 
  Extrinsic 
  compression 
  Pulmonary 
  embolism  
(Figure 5) 
Oncologic Emergencies and Urgencies 
Richard S. Pieters, MD 
Joyce Rosenfeld, MD 
Andrew Chen, MD 
James Liebmann, MD 
19 
Oncologic Emergencies and Urgencies 
11 February 2015 
Airways may be blocked in three ways. The most common cause of 
blockage is a mucous plug, which can be mechanically dislodged. 
Most lung cancer patients have some form of chronic obstructive 
pulmonary disease, which places them at increased risk of mucous 
plugs. Tumor within the trachea or main stem airways causes 
intrinsic compression. Tumor outside can collapse the airways 
causing extrinsic compression. 
Any of these pathophysiologies can trigger post-obstructive 
pneumonia. Bacteria, which normally are swept out by the cilia of the 
normal lung epithelium, become trapped behind the obstruction, and 
infect the parenchyma of the lung distal to the obstruction. Tumor 
growth can also destroy enough lung tissue to push already 
compromised lung function over the edge. Lung collapse due to 
reactive or malignant pleural effusion or pneumothorax can push 
even healthy lungs into dysfunction. 
Presentation 
The patients tend to present tripoding and sitting bolt upright, with a 
history of sleeping in a chair for a few days. They are laboring to 
breathe with severe dyspnea at rest. If the tumor is in the upper 
airway, the presentation may be dominated by stridor. Once 
intubated, or once they have undergone tracheotomy, they re-
oxygenate rapidly, unless the blockage is distal to the tip of the 
endotracheal tube. 
Management 
If the problem is caused by a mucous plug, then suction may relieve 
the symptoms. If the issue is intrinsic compression, and the 
bronchoscope can be passed through the stenosis, laser may be 
used to unblock the tube, and/or perhaps a stent may be placed. But 
then the tumor must be treated, or it will often rapidly re-grow and re-
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obstruct. Extrinsic compression may, in unusual circumstances, be 
amenable to a stent. Usually the symptom will only respond to a 
treatment which actually shrinks the tumor, either chemotherapy or 
more usually, radiotherapy. Intrinsic obstruction may be amenable to 
endoluminal brachytherapy; but the dose from this procedure will not 
reach out to effectively treat a tumor causing extrinsic compression. 
  
Patients with stridor and upper airway blockage can be readily 
treated by tracheotomy, and any physician may find it necessary to 
perform this lifesaving procedure.(Figure 6).  If the tumor 
compressing the trachea is in the low anterior neck, for example 
anaplastic cancer of the thyroid, attempting tracheotomy is extremely 
dangerous. Cutting through the tumor can cause significant bleeding, 
and may then allow the tumor to grow down into the trachea. In this 
circumstance, even biopsy may be dangerous, and tracheotomy 
should not be attempted. 
 
  
 
 
Figure 6. A 39 yo male with a rapidly enlarging mass in the right neck over a 
one month period presents with severe shortness of breath. Figure 5a is 
from a CT of the neck at presentation showing a large mass in the right 
neck with marked encroachment on the upper airway. This patient required 
an urgent tracheostomy as shown on Figure 6b. University of 
Massachusetts Medical School, Department of Radiology. 
 
  
Return to beginning of chapter  
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Superior Vena Cava Syndrome (SVC) 
Etiology 
Tumor growing in the thoracic inlet, can compress the lymphatic 
channels and great veins returning blood to the superior vena cava 
from the upper extremities and the head. As the flow slows, a clot 
may develop and extend down into the SVC (Figure 7a & b). The 
arteries are under sufficient pressure that they are rarely 
compressed, so fluid builds up in one or both arms and head. At this 
point, jugular venous distension develops, even when the patient is 
sitting perfectly upright, and the face and/or arm(s) swell (Figure 7c& 
d). Subsequently, intracranial pressure may increase; patients then 
complain of headache, and the ocular discs may bulge. As the 
condition tends to be sub-acute the small veins (collaterals) on the 
chest wall will dilate, to allow blood to return to the heart. The most 
dangerous acute complication is that the trachea, which has a 
membranous wall posteriorly, behind the partial cartilaginous rings, 
may become compressed, causing respiratory distress. If the airway 
does not become compromised, the condition tends to resolve over a 
period of several weeks as the vessels recannulate. 
Presentation 
SVC syndrome is most easily recognized when the patient presents 
with significant swelling of the arms, neck and head and with jugular 
venous distension even when the patient is straight upright. The 
initial symptoms may be as subtle as a swollen finger with difficulty 
removing a ring. The swelling may progress to a single extremity and 
then to the head. There is often a palpable mass in the 
supraclavicular fossa, sometimes in the anterior neck. As symptoms 
progress, signs of increased intracranial pressure may appear (See 
Increased Intracranial Pressure section of this chapter). Ultimately, a 
late sign is dilation of the subcutaneous veins on the chest. However, 
the most ominous symptom is respiratory distress from tracheal 
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compression. This is a late sign as well, but often occurs before the 
veins dilate (See Respiratory Compromise section in this chapter). 
 
Figure 7. This is a 73 yo male complaining of headaches and dyspnea. 
Figure 7a demonstrates a left mediastinal mass. This mass infiltrates most 
of the upper mediastinum, surrounding and compressing the superior vena 
cava indicated by the yellow arrow on Figure 7b. Venous congestion 
results in facial edema as in Figure 7c, with edema of the lower eyelids. 
Figure 7d. Demonstrates venous distention in the neck and petechia from 
superficial capillary hemorrhages. University of Massachusetts Medical 
School, Department of Radiology 
 
 
  
Treatment  
In many instances, superior vena cava compression may be the first 
manifestation of a malignancy. It is imperative that a pathologic 
diagnosis of an underlying cancer be obtained before starting 
treatment. If the mediastinal mass is the only site of tumor, then that 
should be biopsied. In the past, there was concern that elevated 
venous pressure from the mass would increase the risks associated 
with biopsies. Reviews of mediastinal mass biopsies in patients with 
superior vena cava syndrome have not shown an increased risk of 
complications compared with similar biopsies done in patients 
without the syndrome. 
 
  
Once a diagnosis is made, treatment should be directed at the 
underlying cancer. If the tumor is an untreated lymphoma or 
leukemia, chemotherapy has an excellent chance of providing 
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prompt tumor shrinkage. If the tumor is a solid malignancy (lung, 
breast, etc.), initial treatment should include radiation therapy. 
Return to beginning of chapter 
Brain Metastases 
Brain metastases are a relatively frequent complication of cancer; the 
annual incidence is almost 200,000 cases in the United States. 
About half of these cases arise from lung cancer; breast cancer is 
the next most common site of origin and melanoma is the third 
common malignancy. There is a concept called the fertile field; 
metastases from certain cancers tend to spread to particular organs, 
and the brain is particularly affected by metastases from lung, breast 
and melanoma. Any cancer can give rise to brain metastases and 
today, as patients are living longer with cancer, more patients are 
presenting with brain lesions from previously unusual primary sites. 
Once brain metastases are discovered, life expectancy is typically 
measured in months, and uncontrolled lesions can cause rapid 
neurologic deterioration. After treatment, patients whose extra-cranial 
disease is controlled will do better than those whose disease is not, 
and good performance status patients will live longer than poor 
performance status patients. 
Presentation 
Patients with brain metastases tend to present with symptoms of 
increased intracranial pressure, (headache, nausea and possibly 
vomiting), mental status changes, focal motor weakness, visual field 
cuts, papilledema, symptoms of a cerebral vascular accident or 
seizure. While the initial workup in an emergency room almost 
always includes a CT scan (Figure 8), an MRI of the brain with 
gadolinium (Figure 9.) provides far more information as to the extent 
of disease. Definitive treatment decisions virtually require that an 
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MRI be obtained, so if an MRI is equally available and time permits, 
the CT may be omitted. 
 
 
Figure 8. CT of the brain from a 63 year old man who presented with 
intractable nausea and vomiting demonstrates a hyperdense mass in the 
right cerebellum. Differential diagnoses include hematoma, hemorrhagic 
infarct, or neoplasm. University of Massachusetts Medical School, 
Department of Radiology 
 
  
 
 
Figure 9. MRI of same patient as Figure 8 shows that there are actually two 
lesions in the cerebellum favoring the diagnosis of metastasis. This 
prompted a search for the primary site. The patient was found to have a 
colonic mass from adenocarcinoma. University of Massachusetts Medical 
School, Department of Radiology 
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Management  
Initial management of brain metastasis is dexamethasone. This 
steroid decreases the peri-tumoral edema, thereby decreasing the 
intracranial pressure and mass effect. The patient's neurologic status 
will often improve rapidly after the initial administration of 
dexamethasone. Sometimes mannitol may be required to further 
decrease the intracranial pressure (ICP). 
 
  
Patients who have presented with a seizure require effective 
anticonvulsant therapy. In the past, such therapy was initiated 
prophylactically to prevent seizures. This practice has been 
discouraged recently in patients who do not present with seizures. 
Randomized trials of prophylactic anticonvulsants in patients with 
brain metastases showed no reduction in the risk of developing 
seizures. Hence, prophylactic anticonvulsants provide no benefit and 
merely expose patients needlessly to side effects of the drugs. 
Nonetheless patients with brain metastases are at risk of sudden 
neurologic deterioration due to CVA, nausea or seizure. It is 
important that all such patients are instructed to stop driving, at least 
until their neurologic situation is clear and stable. 
 
  
In patients for whom brain metastases are the presenting sign of 
malignancy, a search for a primary cancer is in order. This should not 
delay the start of treatment to the brain. If there is no preexisting 
diagnosis of malignancy, a biopsy is performed. Occasionally 
evidence of increased intracranial pressure or adverse medical 
condition may preclude this. 
 
  
Today, management of brain metastases is a multi-disciplinary effort. 
Traditionally, surgery was restricted to biopsy of previously 
undiagnosed cancers presenting with brain metastases or 
sometimes proving metastatic status if the brain lesion is the first 
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known metastasis. Sometimes this biopsy would take the form of a 
resection of the lesion. However, the mainstay of treatment was 
palliative whole brain radiotherapy. The traditional palliative dose of 
radiation is radiobiologically insufficient to control bulk tumor deposits 
long term; it was adequate only because of the patient’s short life 
expectancy. 
  
For limited numbers of metastases (usually four or less), 
metastectomy or radiosurgery offers a chance of long-term control of 
the individual lesions. Which of these treatments is more effective 
has not yet been demonstrated. The role of post-operative or post 
radiosurgery whole brain radiotherapy is not yet clear. It does not 
extend survival, but does decrease the incidence of further brain 
metastases, and this appears to enhance quality of life, although it 
has also been demonstrated to impact memory. Whole brain 
radiation may be used prior to radiosurgery in selected patients. 
 
Return to beginning of chapter  
  
Carcinomatous Meningitis  
Carcinomatous or lymphomatous meningitis is an unfortunate 
complication of malignancy. Seen most often in patients with breast 
cancer, lung cancer, acute leukemia, or non-Hodgkin, as well as 
certain pediatric tumors, any cancer diagnosis can give rise to this 
condition. It arises from cancer cells that have spread into the 
cerebrospinal fluid (CSF) and establish tumors on the meninges. 
This can occur anywhere in the central nervous system, from the 
outpouchings around the cranial nerves to the bottom of the cauda 
equina. 
 
  
Presentation  
Sometimes, it is an incidental finding on MRI of brain or spine, either 
at initial staging workup or while working up the symptoms described 
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above for brain metastases because the symptoms of nausea and 
headache can be identical. The classic sign that should make a 
physician consider the diagnosis is isolated or multiple cranial nerve 
deficits, especially those, which arise in patterns that cannot be 
explained, based on a single bony metastasis in the base of the 
skull. This is referred to as a non-anatomic pattern. Back pain or 
dermatome pain or numbness (Brown-Seguard Syndrome) may be 
symptoms of malignant meningitis. If untreated, patients may 
experience progressive loss of function in additional cranial nerves 
and these losses may be irreversible. Physical examination of the 
cranial nerves, which can be done very rapidly, is an important part 
of the examination of cancer patients. 
  
Management  
Initial management involves steroid therapy as for brain metastases. 
The patient must be assessed for increased intracranial pressure, as 
a lumbar puncture (spinal tap) to obtain cells to confirm diagnosis 
and injection of intrathecal chemotherapy is the next step. 
Radiotherapy to the whole brain, the base of the skull and the 
posterior half of the orbits, to encompass the entire outpouchings of 
the meninges around the cranial nerves is used to treat the cranial 
component of carcinomatous meningitis, since intrathecal 
chemotherapy is unlikely to effectively reach the outpouchings of the 
meninges around the cranial nerves . When intrathecal 
chemotherapy is utilized, it can be injected through a lumbar 
puncture. However, often an Ommaya reservoir is placed under the 
scalp, with a catheter extending into the lateral ventricle to deliver the 
therapy less traumatically and more effectively. 
 
  
Return to beginning of chapter  
  
Conclusion  
Every clinician must understand oncologic emergencies and  
Oncologic Emergencies and Urgencies 
Richard S. Pieters, MD  
Joyce Rosenfeld, MD 
Andrew Chen, MD 
James Liebmann, MD 
 
 
28 
Oncologic Emergencies and Urgencies 
11 February 2015 
urgencies, because early diagnosis, appropriate treatment and 
consultation are critically important to preservation of function, quality 
of life and sometimes even preservation of life. Heightened suspicion 
for these conditions is required for any patient with even a remote 
history of malignant diagnosis. And any of these oncologic 
emergencies or urgencies can arise in patients with no prior history 
of malignancy as the first sign of cancer. 
  
Thought Questions  
1. A 27 year old woman comes to the emergency room extremely 
short of breath. A chest CT shows a large thoracic mass with 
compression of the trachea. A physician asks a radiation 
oncologist to radiate the mass. 
 
  
A. Why is this probably not the best thing to do at this point? Expert Answer 
 
 
 
 
 
 
 
 
 
 
  
  
B. What should be done before starting any tumor directed 
treatment? 
Expert Answer 
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2. A 67 year old woman is brought to the emergency room by her 
family because she has become increasingly lethargic. Initial 
labs in the ER show a calcium level of 16.3 mg/dl (normal 8.5-
10.5). 
 
A. What information from a history and physical exam would be 
helpful at this point? 
Expert Answer 
 
 
 
 
 
 
 
 
 
  
  
  
B. What other laboratory information is needed? Expert Answer 
 
 
 
 
 
 
  
  
C. What therapy should be started immediately? Expert Answer 
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3. A 48 year old man comes to his doctor complaining of severe 
mid thoracic back pain. On exam he is hyperreflexive at his 
knees and ankles and has trouble supporting his weight. He 
had a melanoma removed from his arm four years ago.  
While waiting for a MRI of his spine, what treatment could you 
start? 
Expert Answer 
 
 
 
  
  
B. How would your approach differ if he had a history of 
intravenous drug abuse and now was febrile? 
Expert Answer 
 
 
 
  
  
  
  
  
4. A 65 yo man presents with asymmetric sensorineural hearing 
loss and worsening facial droop on the right. Axial MRI images 
through the internal auditory canals (IACs) demonstrates a 
lesion in the right internal auditory canal.  
 
 
 
Figure 10. Axial FIESTA MRI sequence. University of Massachusetts 
Medical School, Department of Radiology. 
Notice that the normal left side is filled with CSF which on this 
sequence is bright. Which cranial nerves run through the IACs? 
 
 
 
 
 
Oncologic Emergencies and Urgencies 
Richard S. Pieters, MD 
Joyce Rosenfeld, MD 
Andrew Chen, MD 
James Liebmann, MD 
31 
Oncologic Emergencies and Urgencies 
11 February 2015 
Can this explain the cause of the symptoms? 
Expert Answer 
Figure 11. Axial T1 fat saturated MRI sequence post contrast. 
University of Massachusetts Medical School, Department of 
Radiology. 
After administration of contrast, the lesion demonstrates 
homogeneous enhancement. This is most consistent with a 
vestibular schwannoma. 
Glossary 
Glisson’s capsule- The fibrous covering of the liver 
Radiosensitive– Tumors which shrink rapidly with radiation treatment 
Paraneoplastic- Signs or symptoms related to a cancer but not due 
to a direct anatomic effect of cancer cells or tumors 
Performance status– A measure of how functional a patient is at a 
point in time. Good performance status patients are active and can 
care for themselves; poor performance status patients may spend 
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most of their days in bed and require considerable support in 
activities of daily living. 
RANK- RANK is the receptor for RANK-Ligand (RANKL) and helps 
regulate osteoclast differentiation and activation. It is associated with 
bone remodeling and repair, among many other functions. 
Tripoding- Patient seated forward, hands on knees, chin extended, 
struggling to breathe. 
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